HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


And the HBA packaging winners are...

This article was originally published in The Rose Sheet

Executive Summary

Diesel Green by Marbert wins HBA Global Expo International Package Design Grand Award, as well as Limited Distribution Fragrance award in New York City Oct. 14. Mass distribution fragrance winner was Mary Kay's Velocity, and mass distribution skin care winner was Reflect.com. Cosmetics category winner was Chanel's Artist Palette; Additional winners include Futuresse by Biodroga for skin care (limited distribution) and PureOlogy Serious Colour Care by Pureology for personal care. Packaging awards were selected by 30 judges from leading marketing companies, HBA says. Individuals honored were: Estee Lauder Senior VP Roger Caracappa for Packaging Executive of the Year; Revlon ExecVP Neil Scancarella for Lifetime Achievement in Product Development; and Procter & Gamble Cosmetic team Lee Ellen Drechsler, Tom Rabe and Ed Smith for New Product Technical Team...

You may also be interested in...

QUOTED. 26 February 2020. Mark Leahey.

In an exclusive interview with Medtech Insight, Mark Leahey, president of the Medical Device Manufacturers Association (MDMA), said the previous four Medical Device User Fee negotiations with the US FDA have set a strong foundation for the industry and the next round of negotiations should focus on tweaking past deals that are already in place. See what MDMA's president, Mark Leahey, said about it here.

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts